Clinical Trials

Lavender vs Zolpidem Sleep Quality During Diagnostic PSG

Condition:   Sleep
Interventions:   Other: Lavender Aromatherapy;   Drug: Zolpidem
Sponsor:   HealthPartners Institute
Completed

Wed, 25 Sep 2019 12:00:00 EDT

Fed Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Tablets

Conditions:   Healthy;   Therapeutic Equivalency
Interventions:   Drug: Zolpidem Tartrate 10 mg tablet;   Drug: Zolpidem Tartrate 10 mg tablet (Ambien®)
Sponsor:   Mutual Pharmaceutical Company, Inc.
Completed

Tue, 15 Apr 2008 12:00:00 EDT

Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Under Fasting Conditions

Condition:   Healthy
Interventions:   Drug: Zolpidem Tartrate 10 mg tablet;   Drug: Zolpidem Tartrate 10 mg tablet (Ambien®)
Sponsor:   Mutual Pharmaceutical Company, Inc.
Completed

Wed, 28 May 2008 12:00:00 EDT

Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia

Condition:   Chronic Insomnia
Interventions:   Drug: Ramelteon and zolpidem;   Drug: Placebo and zolpidem
Sponsor:   Takeda
Completed

Wed, 27 Jun 2007 12:00:00 EDT

Proton MRS Study of SSRI-Zolpidem Interactions

Condition:   Depression
Interventions:   Drug: Zolpidem;   Other: Placebo
Sponsors:   Mclean Hospital;   Brain & Behavior Research Foundation
Completed

Wed, 13 Mar 2013 12:00:00 EDT

Use of Low-dose Zolpidem in Parkinson's Disease

Condition:   Parkinson Disease
Interventions:   Drug: Zolpidem;   Other: Placebo
Sponsors:   Aston University;   University Hospital Birmingham NHS Foundation Trust
Completed

Wed, 08 Aug 2018 12:00:00 EDT

Zolpidem CR and Hospitalized Patients With Dementia

Conditions:   Dementia;   Alzheimer Disease;   Dementia, Vascular;   Sleep Disorders;   Circadian Dysregulation
Interventions:   Drug: Zolpidem CR;   Drug: Placebo
Sponsors:   Massachusetts General Hospital;   Sanofi
Completed

Thu, 25 Dec 2008 12:00:00 EST

Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing

Conditions:   Insomnia;   Primary Insomnia;   Psychophysiologic Insomnia
Interventions:   Drug: Zolpidem;   Drug: Sugar Pill
Sponsors:   University of Rochester;   Sanofi-Synthelabo
Completed

Mon, 12 Sep 2005 12:00:00 EDT

A Comparison of Midazolam and Zolpidem as Oral Premedication in Children

Conditions:   Parental/Caregiver Anxiety;   Child's Anxiety
Interventions:   Drug: zolpidem;   Drug: Midazolam
Sponsor:   Loma Linda University
Completed

Wed, 26 Mar 2014 12:00:00 EDT

Efficacy and Safety of 5 mg Sublingual Zolpidem vs 10mg Oral Zolpidem in the Induction and Maintenance of Sleep in Patients With Primary Insomnia

Condition:   Primary Insomnia
Intervention:   Drug: Zolpidem Hemitartrate
Sponsors:   EMS;   Associação Fundo de Incentivo à Pesquisa
Completed

Thu, 11 Jul 2013 12:00:00 EDT

Biolab Zolpidem Orodispersible 1.0 mg, 1.75 mg and 3.5 mg to Treat Maintenance Insomnia Disorder.

Condition:   Insomnia Disorder
Intervention:   Drug: Zolpidem
Sponsor:   Biolab Sanus Farmaceutica
Not yet recruiting

Thu, 21 Mar 2019 12:00:00 EDT

Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions

Condition:   Healthy
Interventions:   Drug: Zolpidem 10 mg tablets;   Drug: AMBIEN® 10 mg tablets
Sponsor:   Teva Pharmaceuticals USA
Completed

Mon, 02 Feb 2009 12:00:00 EST

Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions

Condition:   Healthy
Interventions:   Drug: Zolpidem 10 mg tablets;   Drug: AMBIEN® 10 mg tablets
Sponsor:   Teva Pharmaceuticals USA
Completed

Mon, 02 Feb 2009 12:00:00 EST

The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females

Condition:   Prostatic Neoplasms
Intervention:   Drug: Zolpidem
Sponsor:   National Cancer Institute (NCI)
Recruiting

Mon, 19 Feb 2018 12:00:00 EST

CBT-I or Zolpidem/Trazodone for Insomnia

Condition:   Chronic Insomnia
Interventions:   Drug: Zolpidem;   Behavioral: Internet Cognitive Behavioral Therapy for Insomnia (CBT-I);   Drug: Trazodone
Sponsors:   California Pacific Medical Center Research Institute;   Patient-Centered Outcomes Research Institute;   University of Pittsburgh;   University of Arizona;   University of Virginia;   University of Illinois at Chicago
Not yet recruiting

Mon, 13 Jul 2020 12:00:00 EDT

Sleep and Breathing in the General Population - Chemical Stimuli

Condition:   Sleep-disordered Breathing
Intervention:   Drug: Zolpidem
Sponsors:   Wayne State University;   National Institutes of Health (NIH)
Completed

Fri, 22 Jan 2021 12:00:00 EST

Study to Validate the Questionnaire Called IDSIQ™ in Patients With Insomnia Disorder

Condition:   Insomnia Disorder
Intervention:   Drug: Zolpidem
Sponsor:   Idorsia Pharmaceuticals Ltd.
Completed

Fri, 17 Feb 2017 12:00:00 EST

A Study to Compare Efficacy and Safety of Zolpidem Modified Release Formulation Versus Zolpidem in Insomnia Patients

Conditions:   Sleep Initiation and Maintenance Disorders;   Primary Insomnia
Interventions:   Drug: Zolpidem MR;   Drug: Zolpidem IR
Sponsors:   Astellas Pharma Inc;   Astellas Pharma Taiwan, Inc.
Completed

Fri, 13 Aug 2010 12:00:00 EDT

Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 3.5 mg Formulation

Condition:   Healthy
Interventions:   Drug: zolpidem hemitartarate tablet 3.5 mg (fasting + post-prandial);   Drug: zolpidem hemitartarate tablet 3.5 mg (post-prandial + fasting)
Sponsor:   Biolab Sanus Farmaceutica
Completed

Wed, 29 Jun 2016 12:00:00 EDT

A Study of FK199B to Compare Efficacy With Zolpidem by Polysomnography in Patients With Insomnia

Condition:   Sleep Initiation and Maintenance Disorders
Interventions:   Drug: FK199B;   Drug: Zolpidem
Sponsor:   Astellas Pharma Inc
Completed

Wed, 21 Oct 2009 12:00:00 EDT

Partial Reinforcement II: Three Approaches to Maintenance Therapy for Chronic Insomnia

Conditions:   Insomnia;   Insomnia Chronic
Intervention:   Drug: Zolpidem tartrate
Sponsors:   University of Pennsylvania;   National Institutes of Health (NIH);   National Institute on Aging (NIA)
Recruiting

Thu, 13 Dec 2018 12:00:00 EST

Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Zolpidem Tartrate Tablets Under Fasted Conditions

Condition:   Healthy
Intervention:   Drug: Zolpidem Tartrate Tablets 10 mg
Sponsor:   Torrent Pharmaceuticals Limited
Completed

Wed, 15 Jul 2009 12:00:00 EDT

A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia

Condition:   Insomnia
Interventions:   Drug: zolpidem tartrate sublingual tablet;   Drug: Placebo
Sponsor:   Transcept Pharmaceuticals
Completed

Fri, 27 Apr 2007 12:00:00 EDT

Reducing Suicidal Ideation Through Insomnia Treatment

Conditions:   Insomnia;   Depression;   Suicidal Ideation
Interventions:   Drug: Zolpidem-CR;   Drug: Placebo
Sponsors:   Augusta University;   National Institute of Mental Health (NIMH);   Wake Forest University Health Sciences;   University of Wisconsin, Madison;   Duke University
Completed

Fri, 21 Sep 2012 12:00:00 EDT

Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem

Condition:   Healthy
Intervention:   Drug: eszopiclone, zolpidem, placebo
Sponsors:   Kettering Health Network;   Abiant, Inc.;   Sunovion
Withdrawn

Wed, 29 Oct 2008 12:00:00 EDT

Pharmacokinetics of Zolpidem Orodispersible Tablet

Condition:   Healthy Volunteers
Intervention:   Drug: Zolpidem Hemitartarate
Sponsor:   Biolab Sanus Farmaceutica
Withdrawn

Wed, 18 Nov 2015 12:00:00 EST

Zolpidem or Exercise for Insomnia?

Condition:   Chronic Insomnia
Interventions:   Drug: Zolpidem;   Behavioral: Exercise
Sponsor:   Universidade Federal de Goias
Completed

Fri, 19 May 2017 12:00:00 EDT

Polysomnographic Study Comparing the Use of Dexmedetomidine and Zolpidem to Induce Natural Sleep

Condition:   Insomnia
Interventions:   Drug: Dexmedetomidine;   Drug: Zolpidem
Sponsors:   Massachusetts General Hospital;   National Institutes of Health (NIH)
Completed

Mon, 05 Dec 2011 12:00:00 EST

Effect Of Treatment With Oral Zolpidem On Polysomnography And Actigraphy Measures In Healthy Volunteers

Condition:   Methodology Study
Interventions:   Drug: placebo;   Drug: zolpidem
Sponsor:   Pfizer
Completed

Wed, 16 Jul 2008 12:00:00 EDT

The Role of Sleep in the Treatment of Cannabis Use Disorders

Condition:   Drug Addiction
Interventions:   Drug: Zolpidem extended-release;   Behavioral: MET/CBT
Sponsors:   Johns Hopkins University;   National Institute on Drug Abuse (NIDA)
Completed

Thu, 13 Sep 2012 12:00:00 EDT

Effects of Zolpidem CR® in Sleep and Heart Recovery in Cardiac Intensive Care Unit Patients

Conditions:   Acute Coronary Syndrome;   Sleep Deprivation
Interventions:   Drug: Zolpidem CR 12.5mg;   Drug: Placebo
Sponsors:   Associação Fundo de Incentivo à Pesquisa;   Conselho Nacional de Desenvolvimento Científico e Tecnológico
Unknown status

Mon, 12 Aug 2013 12:00:00 EDT

Bioequivalence Study of Zolpidem 10mg Tablets Under Fasting Conditions

Condition:   Healthy
Intervention:   Drug: Zolpidem 10mg tablets
Sponsor:   Ranbaxy Laboratories Limited
Completed

Fri, 24 Oct 2008 12:00:00 EDT

A Study to Evaluate Efficacy and Safety of Zolpidem Modified Release Formulation in Insomnia Patients

Conditions:   Sleep Initiation and Maintenance Disorders;   Primary Insomnia
Interventions:   Drug: Zolpidem MR;   Drug: Estazolam
Sponsor:   Astellas Pharma Inc
Completed

Tue, 11 Aug 2009 12:00:00 EDT

A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia

Condition:   Insomnia
Interventions:   Drug: zolpidem tartrate sublingual tablet 3.5mg;   Drug: zolpidem tartrate sublingual tablet 1.75mg;   Drug: Placebo
Sponsor:   Transcept Pharmaceuticals
Completed

Mon, 25 Sep 2006 12:00:00 EDT

Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia.

Condition:   Sleep Initiation and Maintenance Disorders
Interventions:   Drug: zolpidem tartrate;   Drug: sodium oxybate;   Drug: Matching Placebos
Sponsor:   Stanford University
Completed

Tue, 03 Oct 2006 12:00:00 EDT

Electrophysiological and Neuroimaging Correlates of the Effect of Zolpidem in Patients With Focal Dystonia

Condition:   Focal Dystonia
Interventions:   Drug: Zolpidem;   Drug: Placebo
Sponsors:   University Medical Centre Ljubljana;   Slovenian Research Agency;   Clinical Centre of Serbia
Completed

Thu, 31 Dec 2020 12:00:00 EST

Two Contrasting Interventions for Sleep Management

Conditions:   Primary Insomnia;   Secondary Insomnia
Interventions:   Drug: Zolpidem;   Behavioral: Mind-Body Bridging
Sponsors:   University of Utah;   Evans Army Community Hospital
Completed

Tue, 05 Mar 2013 12:00:00 EST

Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 1.75 mg Formulation

Condition:   Healthy
Interventions:   Drug: zolpidem hemitartarate 1.75 mg - Sequency 1;   Drug: zolpidem hemitartarate 1.75 mg - Sequency 2
Sponsor:   Biolab Sanus Farmaceutica
Completed

Mon, 27 Jun 2016 12:00:00 EDT

Bioequivalence Study of Zolpidem 10 mg Tablets Under Fed Conditions

Condition:   Healthy
Intervention:   Drug: Zolpidem 10mg tablets
Sponsor:   Ranbaxy Laboratories Limited
Completed

Fri, 24 Oct 2008 12:00:00 EDT

Sleep Satisfaction and Psychomotor Performance of Adults

Condition:   Sleep Disorders
Intervention:   Drug: ZOLPIDEM
Sponsor:   Sanofi
Completed

Thu, 01 Apr 2010 12:00:00 EDT

Use of Zolpidem in Parkinson's Disease

Condition:   Parkinson's Disease
Interventions:   Drug: Levodopa;   Drug: Zolpidem first dose;   Drug: Zolpidem second dose;   Drug: sugar pill
Sponsor:   Rush University Medical Center
Withdrawn

Tue, 10 May 2011 12:00:00 EDT

Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Zolpidem Tartrate Tablets Under Fed Conditions

Condition:   Healthy
Interventions:   Drug: Zolpidem Tartrate Tablets 10 mg;   Drug: 'Sanofi-Synthelabo Inc's Ambien® Tablets 10 mg
Sponsor:   Torrent Pharmaceuticals Limited
Completed

Wed, 15 Jul 2009 12:00:00 EDT

Zolpidem (Myslee) Post Marketing Study in Adolescent Patients With Insomnia - Evaluation With Polysomnography

Conditions:   Insomnia;   Sleep Initiation and Maintenance Disorders
Intervention:   Drug: zolpidem
Sponsor:   Astellas Pharma Inc
Completed

Mon, 07 Apr 2008 12:00:00 EDT

Sleep and Endometrial Cancer

Conditions:   Sleep;   Endometrial Neoplasms;   Pain
Interventions:   Drug: zolpidem;   Drug: sugar pill
Sponsor:   University of Pittsburgh
Terminated

Fri, 10 Jul 2009 12:00:00 EDT

The Study of Spectrum of Sleep Disorders in Cirrhotic Patients and the Efficacy of Zolpidem in Cirrhotic Patients With Insomnia

Condition:   Cirrhosis
Interventions:   Drug: Zolpidem;   Drug: placebo
Sponsor:   Institute of Liver and Biliary Sciences, India
Completed

Tue, 30 Jun 2015 12:00:00 EDT

Assess the Effect of Zolpidem, Silenor & Placebo on Arousability, Ataxia/Balance & Cognition in Healthy Volunteers

Condition:   Healthy
Interventions:   Drug: Silenor 6 mg;   Drug: zolpidem 10 mg;   Drug: Placebo
Sponsors:   Currax Pharmaceuticals;   Henry Ford Hospital
Completed

Mon, 02 Feb 2015 12:00:00 EST

Postoperative Sleep Disturbances After Zolpidem Treatment in Fast-track Hip and Knee Replacement

Condition:   Sleep Duration on the First Night After Surgery
Interventions:   Drug: Zolpidem;   Drug: Placebo
Sponsor:   Rigshospitalet, Denmark
Unknown status

Mon, 12 Mar 2012 12:00:00 EDT

Safety and Efficacy of Chronic Hypnotic Use

Condition:   Primary Insomnia
Intervention:   Drug: zolpidem
Sponsor:   Henry Ford Health System
Completed

Tue, 03 Nov 2009 12:00:00 EST

Driving Performance After Middle of the Night Administration of 3.5 mg Zolpidem Tartrate Sublingual Tablet

Condition:   Insomnia
Interventions:   Drug: zopiclone;   Drug: zolpidem tartrate sublingual tablet;   Drug: Placebo (sublingual tablet);   Drug: Placebo
Sponsor:   Transcept Pharmaceuticals
Completed

Tue, 20 Apr 2010 12:00:00 EDT

Differential Effects of Zolpidem Versus Ramelteon in Burned Children

Conditions:   Sleep;   Burns
Interventions:   Drug: zolipidem;   Drug: ramelteon
Sponsors:   Shriners Hospitals for Children;   Children's Hospital Medical Center, Cincinnati
Completed

Thu, 04 Oct 2007 12:00:00 EDT

Efficacy and Safety Assessment of ZOlpidem (Stilnox CR) in Patients With Chronic insomNIA

Condition:   Sleep Disorders
Intervention:   Drug: ZOLPIDEM SL800750
Sponsor:   Sanofi
Completed

Wed, 02 Dec 2009 12:00:00 EST

The Role of Partial Reinforcement in the Long Term Management of Insomnia

Condition:   Primary Insomnia
Interventions:   Drug: Zolpidem;   Drug: Placebos
Sponsors:   University of Pennsylvania;   National Institutes of Health (NIH);   National Center for Complementary and Integrative Health (NCCIH)
Completed

Mon, 21 Apr 2008 12:00:00 EDT

Imaging the Effects of Zolpidem and Alprazolam in Healthy Volunteers at 3T

Condition:   Psychotropic Drugs Effects
Interventions:   Drug: Zolpidem;   Drug: Alprazolam;   Drug: Caffeine;   Other: Placebo
Sponsors:   Mclean Hospital;   National Institute on Drug Abuse (NIDA)
Unknown status

Tue, 11 Dec 2012 12:00:00 EST

Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients

Condition:   Obstructive Sleep Apnea Syndrome
Interventions:   Drug: Xyrem (X);   Drug: Zolpidem (Z);   Drug: Modafinil (M);   Drug: Placebo (P)
Sponsor:   Jazz Pharmaceuticals
Completed

Thu, 01 Jul 2004 12:00:00 EDT

A Comparison of the Physiological and Behavioral Effects of Suvorexant and Zolpidem in Healthy Volunteers: A Randomized, Double-blind, Placebo Controlled Study

Condition:   Performance Enhancing Product Use
Interventions:   Drug: Suvorexant 10 mg;   Drug: Zolpidem;   Drug: Placebos
Sponsor:   Walter Reed Army Institute of Research (WRAIR)
Enrolling by invitation

Tue, 18 Feb 2020 12:00:00 EST

The Efficacy of Lower Dose Zolpidem for Achieving Satisfactory Sleep in Women With Disordered Sleep

Condition:   Sleep Disorder
Intervention:   Drug: Zolpidem
Sponsors:   Rhode Island Hospital;   Vitae Industries, Inc
Unknown status

Mon, 24 Dec 2018 12:00:00 EST

Ambien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With Lexapro

Condition:   Insomnia
Intervention:   Drug: zolpidem tartrate
Sponsor:   Sanofi
Completed

Fri, 24 Feb 2006 12:00:00 EST

Multimodal Sleep Pathway for Shoulder Arthroplasty

Conditions:   Sleep Disturbance;   Shoulder Arthritis;   Arthroplasty Complications;   Perioperative/Postoperative Complications
Intervention:   Drug: Zolpidem
Sponsor:   University of California, San Francisco
Completed

Fri, 01 Sep 2017 12:00:00 EDT

A Double-blind, Group-comparison Study Using Zolpidem (Myslee) as a Comparative Drug in Patients With Insomnia

Conditions:   Sleep Initiation and Maintenance Disorders;   Sleep Disorders
Interventions:   Drug: Zolpidem MR;   Drug: Zolpidem
Sponsor:   Astellas Pharma Inc
Completed

Tue, 31 Jan 2006 12:00:00 EST

Treatment of Disturbed Sleep in Progressive Supranuclear Palsy (PSP)

Condition:   Treatment
Interventions:   Drug: Suvorexant;   Drug: Zolpidem;   Drug: Placebo oral capsule
Sponsors:   University of California, San Francisco;   US Department of Veterans Affairs
Recruiting

Wed, 10 Jul 2019 12:00:00 EDT

Bioequivalency Study of Zolpidem Tartrate Under Fed Conditions

Condition:   Insomnia
Intervention:   Drug: Zolpidem
Sponsor:   Roxane Laboratories
Completed

Mon, 28 Jan 2008 12:00:00 EST

Bioequivalency Study of Zolpidem Tartrate Under Fasting Conditions

Condition:   Insomnia
Intervention:   Drug: Zolpidem
Sponsor:   Roxane Laboratories
Completed

Mon, 28 Jan 2008 12:00:00 EST

Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Zolpidem (SL800750)
Sponsor:   Sanofi
Completed

Wed, 26 Apr 2006 12:00:00 EDT

Safety of Ramelteon in Elderly Subjects

Condition:   Insomnia
Intervention:   Drug: Ramelteon, zolpidem and placebo
Sponsor:   Takeda
Completed

Thu, 06 Dec 2007 12:00:00 EST

Pilot Study to Evaluate the Duration of Effects on Simulated Car Driving and Cognitive Performance After a Single Dose of JNJ-42847922, Zolpidem and Placebo in Healthy Participants

Condition:   Healthy
Interventions:   Drug: JNJ-42847922;   Drug: Zolpidem;   Drug: Placebo
Sponsor:   Janssen-Cilag International NV
Completed

Mon, 19 Oct 2015 12:00:00 EDT

Enhancing Memory Consolidation in Older Adults

Condition:   Aging
Intervention:   Drug: Zolpidem
Sponsor:   University of California, Irvine
Recruiting

Tue, 04 Sep 2018 12:00:00 EDT

Zolpidem Postmarketing Study in Adolescent Patients With Insomnia

Condition:   Insomnia
Interventions:   Drug: Zolpidem (Myslee®);   Drug: placebo
Sponsor:   Astellas Pharma Inc
Completed

Wed, 07 Feb 2007 12:00:00 EST

Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo

Condition:   Insomnia
Intervention:   Drug: zolpidem tartrate
Sponsor:   Sanofi
Completed

Mon, 30 Jan 2006 12:00:00 EST

Stilnox Treatment in Elderly Patients With Insomnia

Condition:   Insomnia
Intervention:   Drug: Zolpidem
Sponsor:   Sanofi
Completed

Tue, 01 Aug 2006 12:00:00 EDT

A Study to Determine the Abuse Potential of Single Oral Doses of Lemborexant Compared to Zolpidem, Suvorexant and Placebo in Healthy, Non-Dependent, Recreational Sedative Users

Condition:   Insomnia Disorders
Interventions:   Drug: Zolpidem tablets;   Drug: Suvorexant tablets, over-encapsulated;   Drug: Lemborexant tablets;   Drug: Placebo lemborexant;   Drug: Placebo zolpidem;   Drug: Placebo suvorexant
Sponsors:   Eisai Inc.;   Purdue Pharma LP
Completed

Wed, 17 May 2017 12:00:00 EDT

Effect of a Hypocretin/Orexin Antagonist on Neurocognitive Performance

Condition:   Healthy Volunteers
Interventions:   Drug: Almorexant;   Drug: Zolpidem 10mg;   Drug: Placebo
Sponsors:   Northern California Institute of Research and Education;   U.S. Army Medical Research and Development Command
Completed

Thu, 18 Nov 2010 12:00:00 EST

Efficacy and Safety of Zolpidem-MR Administered Over a Long Term Period as Needed for Insomnia (ZOLONG)

Condition:   Sleep Initiation and Maintenance Disorders
Intervention:   Drug: zolpidem-MR (SL800750)
Sponsor:   Sanofi
Completed

Mon, 22 Jan 2007 12:00:00 EST

Optimize Astronaut Sleep Medication Efficacy and Individual Effects

Conditions:   Sleep;   Cognition;   Pharmacologic Actions
Intervention:   Drug: Zolpidem
Sponsor:   National Aeronautics and Space Administration (NASA)
Completed

Wed, 16 May 2018 12:00:00 EDT

Characteristics of Sleep Patterns in Young Adults With and Without Insomnia

Condition:   Sleep Disorders
Interventions:   Drug: Zolpidem;   Drug: Escitalopram;   Drug: Placebo
Sponsors:   University of Pittsburgh;   National Institute of Mental Health (NIMH)
Completed

Thu, 15 Sep 2005 12:00:00 EDT

Investigation of Melatonin and Zolpidem Effect on Postural Instability in Healthy Adult Subjects

Condition:   Postural Instability
Interventions:   Drug: Circadin (R) 2 mg;   Drug: Stilnox (R) 10 mg;   Drug: Placebo
Sponsor:   Neurim Pharmaceuticals Ltd.
Completed

Fri, 21 Jan 2011 12:00:00 EST

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)

Condition:   Insomnia
Interventions:   Drug: Lemborexant;   Drug: Lemborexant-matched placebo;   Drug: Zolpidem tartrate;   Drug: Zolpidem-matched placebo
Sponsor:   Eisai Inc.
Completed

Thu, 26 May 2016 12:00:00 EDT

Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary Insomnia

Condition:   Sleep Initiation and Maintenance Disorders
Interventions:   Drug: zolpidem-MR (modified release);   Drug: zolpidem (SL800750);   Drug: placebo
Sponsor:   Sanofi
Completed

Thu, 06 Mar 2008 12:00:00 EST

Disturbed Sleep Model Study.

Condition:   Sleep Initiation and Maintenance Disorders
Interventions:   Drug: SB-649868;   Drug: Zolpidem;   Drug: Placebo
Sponsor:   GlaxoSmithKline
Completed

Tue, 27 Feb 2007 12:00:00 EST

A Double-blind, Group-comparison P-III Study With Zolpidem MR Using Placebo and Nitrazepam in Insomnia Patients

Condition:   Sleep Initiation and Maintenance Disorders
Interventions:   Drug: zolpidem MR;   Drug: nitrazepam;   Drug: placebo
Sponsor:   Astellas Pharma Inc
Completed

Mon, 11 Sep 2006 12:00:00 EDT

Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in Women

Condition:   Healthy
Interventions:   Drug: Fluoxetine;   Drug: Zolpidem;   Drug: Progesterone
Sponsor:   University of Pennsylvania
Completed

Mon, 12 May 2008 12:00:00 EDT

Study to Investigate the Effects of Melatonin, Temazepam & Zolpidem on Sleep EEG in Men and Women

Condition:   Insomnia
Interventions:   Drug: Prolonged-release melatonin;   Drug: Temazepam;   Drug: Zolpidem;   Drug: Placebo to match melatonin, zolpidem and temazepam
Sponsors:   University of Surrey;   H. Lundbeck A/S
Completed

Thu, 16 Jul 2009 12:00:00 EDT

Insomnia and Daytime Function in Osteoarthritis

Condition:   Sleep Disorders
Intervention:   Drug: zolpidem
Sponsor:   Sanofi
Completed

Mon, 17 Sep 2007 12:00:00 EDT

Memory Consolidation in Pharmacologically Enhanced Naps

Condition:   Sleep
Interventions:   Drug: zolpidem;   Drug: Placebo
Sponsors:   University of California, San Diego;   National Institute of Mental Health (NIMH)
Completed

Wed, 22 Oct 2008 12:00:00 EDT

Estrogen for Treating Depression in Menopausal Women With Hot Flashes and Insomnia

Conditions:   Sleep Initiation and Maintenance Disorders;   Depression
Interventions:   Drug: Estrogen Replacement Therapy;   Drug: Zolpidem;   Drug: placebo
Sponsors:   Hadine Joffe, MD;   National Institute of Mental Health (NIMH)
Completed

Wed, 28 Sep 2005 12:00:00 EDT

Hypnotic Medications and Memory: Effect of Drug Exposure During the Night

Conditions:   Sleep;   Memory
Interventions:   Drug: zaleplon;   Drug: zolpidem extended release;   Drug: bedtime placebo;   Drug: middle of the night placebo
Sponsors:   St. Luke's Hospital, Chesterfield, Missouri;   American Academy of Sleep Medicine
Completed

Fri, 09 Jul 2010 12:00:00 EDT

Hypnotic Intake and Motor and Cognitive Performances at High Altitude

Condition:   Physiology
Interventions:   Drug: Zolpidem;   Drug: Placebo
Sponsor:   Centre d'Expertise sur l'Altitude EXALT
Completed

Fri, 20 May 2016 12:00:00 EDT

Z-Drugs for Sleep Disorders in Alzheimer's Disease

Conditions:   Sleep;   Sleep Disorders;   Insomnia;   Alzheimer's Disease
Interventions:   Drug: Zolpidem;   Drug: Zoplicone;   Drug: Placebo
Sponsor:   Brasilia University Hospital
Completed

Thu, 09 Mar 2017 12:00:00 EST

Combined Behavioral/Pharmacological Therapy for Insomnia

Condition:   Sleep Initiation and Maintenance Disorders
Interventions:   Behavioral: Cognitive-Behavioral Therapy for Insomnia;   Drug: zolpidem tartrate (Ambien);   Drug: Placebo
Sponsors:   Duke University;   National Institute of Mental Health (NIMH)
Completed

Thu, 05 Sep 2002 12:00:00 EDT

Effects of Repeat Dosing of GSK1521498

Condition:   Obesity
Interventions:   Drug: Zolpidem or placebo - Hypnotic drug given for sleep disorders;   Drug: GSK1521498 or placebo
Sponsor:   GlaxoSmithKline
Completed

Mon, 14 Sep 2009 12:00:00 EDT

Improving Sleep Quality in Heart Failure

Conditions:   Sleep Disturbance;   Heart Failure
Interventions:   Drug: Zolpidem Tartrate;   Drug: Placebo oral capsule
Sponsor:   Johns Hopkins University
Completed

Wed, 11 Oct 2017 12:00:00 EDT

Incidence of Delirium in Hip Fracture Patients Randomized to Regular Hypnotics vs Placebo

Conditions:   Hip Fracture;   Delirium
Intervention:   Drug: Zolpidem
Sponsors:   Hvidovre University Hospital;   IMK Fonden
Terminated

Mon, 06 Feb 2006 12:00:00 EST

The Role of Sleep-modulating Drugs in the Recovery of Patients With Disorders of Consciousness

Condition:   Consciousness Disorders
Interventions:   Other: zolpidem tartrate;   Other: melatonin
Sponsor:   Xijing Hospital
Recruiting

Fri, 28 Oct 2016 12:00:00 EDT

Central Sleep Apnea : Physiologic Mechanisms to Inform Treatment

Conditions:   Sleep Disordered Breathing;   Able Bodied
Interventions:   Drug: Acetazolamide + supplemental oxygen + PAP therapy;   Drug: Zolpidem + PAP therapy;   Drug: Buspirone + PAP therapy
Sponsor:   VA Office of Research and Development
Recruiting

Tue, 08 Oct 2019 12:00:00 EDT

Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer

Conditions:   Breast Cancer;   Hot Flashes;   Sleep Disorders
Interventions:   Drug: venlafaxine;   Drug: zolpidem tartrate;   Procedure: management of therapy complications
Sponsor:   Massachusetts General Hospital
Completed

Fri, 11 Jun 2004 12:00:00 EDT

Safety and Efficacy of Chronic Hypnotic Use 2

Condition:   Chronic Insomnia
Interventions:   Drug: placebo;   Drug: Zolpidem CR;   Drug: Eszopiclone
Sponsor:   Henry Ford Health System
Recruiting

Thu, 28 May 2015 12:00:00 EDT

A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia

Condition:   Insomnia
Interventions:   Drug: LEM 5 mg;   Drug: LEM 10 mg
Sponsor:   Eisai Inc.
Completed

Fri, 05 Jul 2019 12:00:00 EDT

Behavioral and Pharmacological Treatment for Insomnia

Condition:   Sleep Initiation and Maintenance Disorders
Interventions:   Behavioral: Cognitive-behavior therapy;   Drug: zolpidem
Sponsors:   Laval University;   National Institute of Mental Health (NIMH)
Completed

Fri, 26 Jul 2002 12:00:00 EDT

Crossover Study to Evaluate the Effect of Lemborexant Versus Placebo and Zolpidem on Postural Stability, Auditory Awakening Threshold, and Cognitive Performance in Healthy Subjects 55 Years and Older

Condition:   Healthy Subjects
Interventions:   Drug: LEM5;   Drug: LEM10;   Drug: ZOL;   Drug: PBO
Sponsors:   Eisai Inc.;   Purdue Pharma LP
Completed

Mon, 02 Jan 2017 12:00:00 EST

Study to Evaluate the Relative Abuse Potential of Almorexant in Recreational Drug Users

Condition:   Abuse Potential Study
Interventions:   Drug: 200 mg almorexant;   Drug: 400 mg almorexant;   Drug: 1000 mg almorexant;   Drug: 20 mg zolpidem;   Drug: 40 mg zolpidem;   Drug: placebo
Sponsor:   Midnight Pharma, LLC
Completed

Tue, 19 Nov 2013 12:00:00 EST

Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia

Condition:   Primary Insomnia
Interventions:   Drug: almorexant;   Drug: Placebo;   Drug: zolpidem
Sponsor:   Midnight Pharma, LLC
Completed

Wed, 06 Feb 2008 12:00:00 EST

ZOlpidem and the stRengthening of pRescription regulatiOn

Condition:   Substance Use Disorders
Intervention:   Other: No interventional study
Sponsor:   Nantes University Hospital
Unknown status

Thu, 12 Jul 2018 12:00:00 EDT

Alternative Dosing Regimens in the Pharmacotherapy of Insomnia

Condition:   Insomnia
Interventions:   Drug: Amitriptyline;   Drug: Zolpidem;   Drug: Placebo
Sponsors:   Philipps University Marburg Medical Center;   Johannes Gutenberg University Mainz;   Philipps University Marburg Coordination Centre for Clinical Trials
Terminated

Thu, 15 May 2014 12:00:00 EDT

Study to Evaluate the Abuse Potential of ACT-541468 in Healthy Recreational Drug Users

Condition:   Healthy Recreational Drug Users
Interventions:   Drug: ACT-541468;   Drug: Suvorexant;   Drug: Zolpidem;   Drug: Placebo
Sponsor:   Idorsia Pharmaceuticals Ltd.
Completed

Wed, 05 Sep 2018 12:00:00 EDT

A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder

Condition:   Insomnia Disorders
Interventions:   Drug: Placebo;   Drug: JNJ-42847922, 5 mg;   Drug: JNJ-42847922, 10 mg;   Drug: JNJ-42847922, 20 mg;   Drug: Zolpidem
Sponsor:   Janssen Research & Development, LLC
Completed

Fri, 15 Dec 2017 12:00:00 EST

A Study of LY2624803 in Participants With Transient Insomnia

Condition:   Transient Insomnia
Interventions:   Drug: LY2624803 - Capsules;   Drug: Zolpidem - Tablets;   Drug: Placebo - Capsules;   Drug: Placebo - Tablets
Sponsor:   Eli Lilly and Company
Completed

Wed, 30 Jan 2013 12:00:00 EST

An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia

Conditions:   Primary Insomnia;   Secondary Insomnia
Interventions:   Drug: LY2624803;   Drug: Placebo;   Drug: zolpidem
Sponsor:   Eli Lilly and Company
Completed

Tue, 04 Nov 2008 12:00:00 EST

Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder

Condition:   Insomnia Disorder
Interventions:   Drug: ACT-541468 5 mg;   Drug: ACT-541468 10 mg;   Drug: ACT-541468 25 mg;   Drug: Zolpidem;   Drug: Placebo 1;   Drug: Placebo 2
Sponsor:   Idorsia Pharmaceuticals Ltd.
Completed

Wed, 20 Jul 2016 12:00:00 EDT

The Effect of Marijuana and Prescription Medications in Mood, Performance and Sleep

Condition:   Marijuana Dependence
Interventions:   Drug: eszopiclone;   Drug: Placebo;   Drug: ramelteon;   Drug: zolpidem
Sponsors:   Johns Hopkins University;   Food and Drug Administration (FDA);   National Institute on Drug Abuse (NIDA)
Completed

Tue, 05 May 2009 12:00:00 EDT

Efficacy and Safety Study of Adipiplon, Placebo and an Active Control in Primary Insomniacs

Condition:   Primary Insomnia
Interventions:   Drug: Adipiplon;   Drug: Placebo;   Drug: Ambien CR
Sponsor:   Neurogen Corporation
Terminated

Fri, 23 May 2008 12:00:00 EDT

Sedative-Anxiolytic Effects on Simulated Driving Performance

Condition:   Psychomotor Impairment
Interventions:   Drug: Alprazolam 2mg (2ALP/PLC);   Drug: Alprazolam 1mg (1ALP/PLC);   Drug: Alprazolam 0.5mg (0.5ALP/PLC);   Drug: Zolpidem 10mg (ZOL/PLC);   Drug: Placebo (PLC/PLC);   Drug: Alprazolam 1mg (PLC/ALC)
Sponsors:   Marion Coe;   National Institute on Drug Abuse (NIDA)
Completed

Fri, 29 Sep 2017 12:00:00 EDT

Safety and the Efficacy of a Sublingual Administration of Flumazenil to Reverse the Effect of Hypnotic Drugs in Healthy Adults

Condition:   Healthy
Interventions:   Drug: Flumazenil;   Drug: Placebo
Sponsor:   Coeruleus Ltd.
Completed

Fri, 19 Feb 2010 12:00:00 EST

A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)

Condition:   Primary Insomnia
Interventions:   Drug: Eszopiclone 1 mg;   Drug: Eszopiclone 2 mg;   Drug: Eszopiclone 3 mg;   Drug: Placebo;   Drug: Zolpidem Tartrate 10 mg
Sponsor:   Eisai Co., Ltd.
Completed

Fri, 10 Oct 2008 12:00:00 EDT

Sequenced Therapies for Comorbid and Primary Insomnias

Conditions:   Insomnia Comorbid to Psychiatric Disorder;   Primary Insomnia
Interventions:   Behavioral: Behavioral Insomnia Therapy;   Drug: Zolpidem;   Drug: Trazodone;   Behavioral: Cognitive Therapy
Sponsors:   Jack Edinger, PhD;   National Institutes of Health (NIH);   National Institute of Mental Health (NIMH)
Completed

Fri, 27 Jul 2012 12:00:00 EDT

A 2-Part Single Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006

Condition:   Insomnia
Interventions:   Drug: E2006 1.0 mg;   Drug: E2006 2.5 mg;   Drug: E2006 5.0 mg;   Drug: E2006 10.0 mg;   Drug: E2006 25.0 mg;   Drug: E2006 50.0 mg;   Drug: E2006 100 mg;   Drug: E2006 200 mg;   Drug: Zolpidem 10 mg;   Drug: E2006 Matched Placebo or Zolpidem Matched Placebo;   Drug: E2006 Matched Placebo
Sponsor:   Eisai Inc.
Completed

Tue, 01 Nov 2011 12:00:00 EDT

SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.

Condition:   Transient Insomnia
Interventions:   Drug: SM-1;   Drug: D+Z;   Drug: D+L;   Drug: Placebo
Sponsor:   Sequential Medicine Ltd
Completed

Mon, 06 Nov 2017 12:00:00 EST

SM-1 vs. an Active Comparator in A Model of Transient Insomnia

Condition:   Transient Insomnia
Interventions:   Drug: SM-1;   Drug: Active Comparator
Sponsor:   Sequential Medicine Ltd
Not yet recruiting

Wed, 20 May 2020 12:00:00 EDT

An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia

Condition:   Transient Insomnia
Interventions:   Drug: SM-1;   Drug: Placebo
Sponsor:   Sequential Medicine Ltd
Not yet recruiting

Thu, 09 Nov 2017 12:00:00 EST

Pharmacovigilance in Gerontopsychiatric Patients

Conditions:   Dementia;   Depression;   Schizophrenia;   Psychosomatic Disorders;   Anxiety Disorders
Interventions:   Drug: Phenobarbital;   Drug: Phenytoin;   Drug: Carbamazepine;   Drug: Oxcarbazepine;   Drug: Valproic Acid;   Drug: Lamotrigine;   Drug: Topiramate;   Drug: Gabapentin;   Drug: Levetiracetam;   Drug: Pregabalin;   Drug: Lacosamide;   Drug: Clonazepam;   Drug: Biperiden;   Drug: Levomepromazine;   Drug: Fluphenazine;   Drug: Perphenazine;   Drug: Perazine;   Drug: Thioridazine;   Drug: Haloperidol;   Drug: Melperone;   Drug: Pipamperone;   Drug: Bromperidol;   Drug: Benperidol;   Drug: Sertindole;   Drug: Ziprasidone;   Drug: Flupentixol;   Drug: Chlorprothixene;   Drug: Zuclopenthixol;   Drug: Fluspirilene;   Drug: Pimozide;   Drug: Clozapine;   Drug: Olanzapine;   Drug: Quetiapine;   Drug: Sulpiride;   Drug: Tiapride;   Drug: Amisulpride;   Drug: Prothipendyl;   Drug: Risperidone;   Drug: Aripiprazole;   Drug: Paliperidone;   Drug: Diazepam;   Drug: Oxazepam;   Drug: Lorazepam;   Drug: Bromazepam;   Drug: Clobazam;   Drug: Alprazolam;   Drug: Hydroxyzine;   Drug: Buspirone;   Drug: Chloral Hydrate;   Drug: Flurazepam;   Drug: Nitrazepam;   Drug: Triazolam;   Drug: Lormetazepam;   Drug: Temazepam;   Drug: Midazolam;   Drug: Brotizolam;   Drug: Zopiclone;   Drug: Zolpidem;   Drug: Zaleplon;   Drug: Melatonin;   Drug: Clomethiazole;   Drug: Diphenhydramine;   Drug: Promethazine;   Drug: Imipramine;   Drug: Clomipramine;   Drug: Opipramol;   Drug: Trimipramine;   Drug: Amitriptyline;   Drug: Nortriptyline;   Drug: Doxepin;   Drug: Maprotiline;   Drug: Amitriptyline oxide;   Drug: Fluoxetine;   Drug: Citalopram;   Drug: Paroxetine;   Drug: Sertraline;   Drug: Fluvoxamine;   Drug: Escitalopram;   Drug: Tranylcypromine;   Drug: Moclobemide;   Drug: Mianserin;   Drug: Trazodone;   Drug: Mirtazapine;   Drug: Bupropion;   Drug: Venlafaxine;   Drug: Reboxetine;   Drug: Duloxetine;   Drug: Agomelatine;   Drug: Pyritinol;   Drug: Piracetam;   Drug: Donepezil;   Drug: Rivastigmine;   Drug: Galantamine;   Drug: Memantine;   Drug: Nicergoline;   Drug: Acamprosate;   Drug: Lithium
Sponsor:   Hannover Medical School
Terminated

Mon, 02 Mar 2015 12:00:00 EST

Effects of Hallucinogens and Other Drugs on Mood and Performance

Condition:   Healthy
Intervention:   Drug: Hallucinogens and psychoactive substances
Sponsor:   Johns Hopkins University
Completed

Mon, 13 Jan 2014 12:00:00 EST

Pilot Study of a Combination Drug Product for Treatment of Short-term Insomnia

Condition:   Short-term Insomnia
Interventions:   Drug: SM-1;   Drug: Comparator;   Drug: Placebo
Sponsors:   Sequential Medicine Ltd;   Clinilabs, Inc.
Completed

Tue, 02 Feb 2016 12:00:00 EST

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Conditions:   Coronavirus Infection (COVID-19);   Pulmonary Arterial Hypertension;   Urinary Tract Infections in Children;   Hypertension;   Pain;   Hyperphosphatemia;   Primary Hyperaldosteronism;   Edema;   Hypokalemia;   Heart Failure;   Hemophilia;   Menorrhagia;   Insomnia;   Pneumonia;   Skin Infection;   Arrythmia;   Asthma in Children;   Bronchopulmonary Dysplasia;   Adrenal Insufficiency;   Fibrinolysis; Hemorrhage;   Attention Deficit Hyperactivity Disorder;   Multisystem Inflammatory Syndrome in Children (MIS-C);   Kawasaki Disease;   Coagulation Disorder;   Down Syndrome
Intervention:   Drug: The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:
Sponsors:   Duke University;   The Emmes Company, LLC;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting

Thu, 20 Feb 2020 12:00:00 EST

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Conditions:   Adenovirus;   Anesthesia;   Anxiety;   Anxiolysis;   Autism;   Autistic Disorder;   Bacterial Meningitis;   Bacterial Septicemia;   Benzodiazepine;   Bipolar Disorder;   Bone and Joint Infections;   Central Nervous System Infections;   Convulsions;   Cytomegalovirus Retinitis;   Early-onset Schizophrenia Spectrum Disorders;   Epilepsy;   General Anesthesia;   Gynecologic Infections;   Herpes Simplex Virus;   Infantile Hemangioma;   Infection;   Inflammation;   Inflammatory Conditions;   Intra-abdominal Infections;   Lower Respiratory Tract Infections;   Migraines;   Pain;   Pneumonia;   Schizophrenia;   Sedation;   Seizures;   Skeletal Muscle Spasms;   Skin and Skin-structure Infections;   Treatment-resistant Schizophrenia;   Urinary Tract Infections;   Withdrawal;   Sepsis;   Gram-negative Infection;   Bradycardia;   Cardiac Arrest;   Cardiac Arrhythmia;   Staphylococcal Infections;   Nosocomial Pneumonia;   Neuromuscular Blockade;   Methicillin Resistant Staphylococcus Aureus;   Endocarditis;   Neutropenia;   Headache;   Fibrinolytic Bleeding;   Pulmonary Arterial Hypertension;   CMV Retinitis;   Hypertension;   Chronic Kidney Diseases;   Hyperaldosteronism;   Hypokalemia;   Heart Failure;   Hemophilia;   Heavy Menstrual Bleeding;   Insomnia
Intervention:   Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
Sponsors:   Daniel Benjamin;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   The Emmes Company, LLC
Completed

Fri, 09 Sep 2011 12:00:00 EDT

Risk and Benefit Assessment of Hypnotic Agents for Sleep Disorders Among Elderly

Condition:   Sleep Disorders
Intervention:   Drug: Exposure to sedative-hypnotic drugs
Sponsors:   China Medical University Hospital;   National Health Research Institutes, Taiwan
Unknown status

Thu, 07 Jan 2016 12:00:00 EST

Orthostatic Hypotension Treatment on Rehab Unit

Conditions:   Orthostatic Hypotension;   Falls
Interventions:   Other: Medication review;   Other: Nutrition/Salt intake;   Other: Education;   Other: Exercise;   Other: Drug Recommendations
Sponsor:   VA Office of Research and Development
Completed

Mon, 14 Dec 2009 12:00:00 EST